Ischemic events in humans are not evenly distributed across the day. To discriminate between temporal differences in the incidence of ischemia and susceptibility to ischemic events, we examined the outcome of global ischemia in a murine model at three time points during the day. Global cerebral ischemia in mice during the light phase impairs survival and exacerbates outcome compared to ischemia at other times of the day. Specifically, mice that underwent cardiac arrest during the light phase had greater numbers of degenerating neurons, greater microglial activation, and increased proinflammatory cytokine production in the ischemia-vulnerable hippocampus, as well as increased locomotor activity. Time-of-day differences were not altered by the melatonin receptor antagonist luzindole. Our results document that brain tissue displays endogenous fluctuations in susceptibility to ischemic damage and demonstrate that small differences in time of onset can significantly influence ischemic outcomes.
Introduction
Ischemic cardiovascular events including silent myocardial ischemia, acute myocardial infarction, sudden cardiac death, and stroke, exhibit marked time-of-day variation with an excess of occurrences in the early morning hours (Cohen et al., 1997; Muller et al., 1987; Rocco et al., 1987; Thompson et al., 1985; Willich et al., 1987) . A confluence of physiological factors may contribute to this temporal variation in ischemic events, including daily maxima in blood pressure, blood coagulability, heart rate, vascular and sympathetic tone, and several neuroendocrine systems (Portaluppi and Lemmer, 2007) . Although there is little doubt that temporal variation exists in the incidence of ischemic cardiovascular events, it remains unknown whether there is daily variation in susceptibility of the brain and other organ systems to ischemic damage.
Circadian organization of physiological processes has been demonstrated across phylogeny ranging from unicellular organisms to the highest order vertebrates (Ishiura et al., 1998; Reppert and Weaver, 2001) . Among vertebrates, endogenous circadian rhythms can be detected in whole organisms, individual organs and tissues, and even single cells (Abe et al., 2002; Stokkan et al., 2001) . Indeed, neurons exhibit daily rhythms in transcription, translation, synaptic activity, and neurotransmitter and neuropeptide secretion (Abe et al., 2002; Herzog, 2007) . The overriding question motivating this study is do daily rhythms in physiology and behavior have potential consequences for susceptibility to disease states?
The central nervous system (CNS) is differentially susceptible to damage in cases of whole-body ischemia and CNS injury is often the proximate cause of death and long term disability from cardiac arrest (Becker et al., 1991; Roine et al., 1993; Krause et al., 1986) . Despite extensive research into the pathophysiology of cerebral ischemia, no broadly effective pharmacotherapy exists (Jastremski et al., 1989; Kofler et al., 2004; Roine et al., 1993) . Therefore, the study of endogenous neuroprotective mechanisms that might provide insights into potential interventions is important (Perez-Pinzon, 2007) . The experiments in this study were designed to test the hypothesis that CNS tissue exhibits daily fluctuations in susceptibility to ischemic damage and to begin to uncover the mechanisms that underlie temporal fluctuations in susceptibility. In order to address this question, a standardized ischemic challenge, cardiac arrest and cardiovascular resuscitation, (CA/CPR) was administered to healthy adult male mice at three different phases of the day [Middle of the light period, (Mid-Light) at the light-dark transition (Light → Dark), and in the middle of the dark period (Mid-Dark)]. To control for nonspecific effects of the surgical procedure, we also conducted the cardiac arrest and cardiopulmonary resuscitation procedure on mice with hypothermic heads (27°C, a condition that protects the CNS from virtually all ischemic damage (Neigh et al., 2004) ). Survival, as well as behavioral, histological, inflammatory, and neuroendocrine Neurobiology of Disease 36 (2009) 352-360 
